Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2018, Article ID 3417190, 9 pages
https://doi.org/10.1155/2018/3417190
Research Article

Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study

1Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China

Correspondence should be addressed to Xiaoli Lan; moc.liamtoh@427037lxl

Received 29 May 2018; Revised 2 September 2018; Accepted 20 September 2018; Published 28 October 2018

Guest Editor: Nicola Toschi

Copyright © 2018 Congcong Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. C. Detterbeck, M. A. Jantz, M. Wallace, J. Vansteenkiste, G. A. Silvestri, and American College of Chest Physicians, “Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition),” Chest, vol. 132, no. 3, pp. 202S–220S, 2007. View at Google Scholar
  2. E. M. Toloza, L. Harpole, F. Detterbeck, and D. C. McCrory, “Invasive staging of non-small cell lung cancer: a review of the current evidence,” Chest, vol. 123, no. 1, pp. 157S–166S, 2003. View at Google Scholar
  3. F. J. Herth, R. Eberhardt, M. Krasnik, and A. Ernst, “Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer,” Chest, vol. 133, no. 4, pp. 887–191, 2008. View at Google Scholar
  4. J. T. Annema, M. I. Versteegh, M. Veseliç, P. Voigt, and K. F. Rabe, “Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging,” Journal of Clinical Oncology, vol. 23, no. 33, pp. 8357–8361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Czarnecka-Kujawa and K. Yasufuku, “The role of endobronchial ultrasound versus mediastinoscopy for non-small cell lung cancer,” Journal of Thoracic Disease, vol. 9, no. 2, pp. S83–S97, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Kumar, R. Dutta, U. Kannan, R. Kumar, G. C. Khilnani, and S. D. Gupta, “Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation,” Annals of Thoracic Medicine, vol. 6, no. 1, pp. 11–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. X. L. Lan, Y. X. Zhang, Z. J. Wu, Q. Jia, H. Wei, and Z. R. Gao, “The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions,” Clinical Radiology, vol. 63, no. 7, pp. 756–764, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Rankin, “[(18)F]2-fluoro-2-deoxy-D-glucose PET/CT in mediastinal masses,” Cancer Imaging, vol. 10, no. 1A, pp. S156–S160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kubota, K. Murakami, T. Inoue et al., “Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study,” Annals of Nuclear Medicine, vol. 25, no. 10, pp. 777–786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. C. Nguyen, A. Kaushik, M. K. Wolverson, and M. M. Osman, “Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? a retrospective study,” Acta Oncologica, vol. 50, no. 5, pp. 670–677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Li, H. Zhang, L. Xing et al., “Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study,” Radiotherapy and Oncology, vol. 102, no. 2, pp. 246–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. J. Cerfolio and A. S. Bryant, “Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer,” Annals of Thoracic Surgery, vol. 83, no. 5, pp. 1826–1829, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Antoch, F. M. Vogt, L. S. Freudenberg et al., “Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology,” JAMA, vol. 290, no. 24, pp. 3199–3206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Rankin, “PET/CT for staging and monitoring non-small cell lung cancer,” Cancer Imaging, vol. 8, pp. S27–S31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Zhu, W. G. Xu, W. C. Ma, X. Y. Song, D. Dai, and L. Zhu, “A comparative study of 18F-FDG PET/CT and CT imaging in detection of axillary lymph node status of breast cancer,” Chinese Journal of Oncology, vol. 37, pp. 388–391, 2010. View at Google Scholar
  16. E. M. Rohren, T. G. Turkington, and R. E. Coleman, “Clinical applications of PET in oncology,” Radiology, vol. 231, no. 2, pp. 305–332, 2004. View at Google Scholar
  17. P. H. Jarritt, K. J. Carson, A. R. Hounsell, and D. Visvikis, “The role of PET/CT scanning in radiotherapy planning,” British Journal of Radiology, vol. 79, no. 1, pp. S27–35, 2006. View at Google Scholar
  18. J. Konishi, K. Yamazaki, E. Tsukamoto et al., “Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings,” Respiration, vol. 70, no. 5, pp. 500–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. Bryant, R. J. Cerfolio, K. M. Klemm, and B. Ojha, “Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer,” Annals of Thoracic Surgery, vol. 82, no. 2, pp. 417–422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Nambu, S. Kato, Y. Sato et al., “Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET,” Annals of Nuclear Medicine, vol. 23, no. 3, pp. 269–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Rizzo, I. Castiglioni, G. Russo et al., “Using deconvolution to improve PET spatial resolution in OSEM iterative reconstruction,” Methods of Information in Medicine, vol. 46, no. 2, pp. 231–235, 2007. View at Publisher · View at Google Scholar
  22. T. P. Graeter, D. Hellwig, K. Hoffmann, D. Ukena, C. M. Kirsch, and H. J. Schäfers, “Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy,” Annals of Thoracic Surgery, vol. 75, no. 1, pp. 231–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. R. V. Venkateswaran, D. J. Barron, W. J. Brawn et al., “A forgotten old disease: mediastinal tuberculous lymphadenitis in children,” European Journal of Cardio-Thoracic Surgery, vol. 27, no. 3, pp. 401–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. S. Tang, Z. G. Yang, W. Deng, H. Shao, J. Chen, and L. Y. Wen, “Differentiation between tuberculosis and lymphoma in mediastinal lymph nodes: evaluation with contrast-enhanced MDCT,” Clinical Radiology, vol. 67, no. 9, pp. 877–883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Xiong, X. Mao, C. Li, Z. Liu, and Z. Zhang, “Posterior mediastinal tuberculous lymphadenitis with dysphagia as the main symptom: a case report and literature review,” Journal of Thoracic Disease, vol. 5, no. 5, pp. E189–E194, 2013. View at Google Scholar
  26. M. Y. Luo, L. Liu, L. S. Lai, Y. X. Dong, W. W. Liang, and J. Qin, “Deepgoing study on intrathoracic tuberculous lymphadenitis in adults using multidetector CT,” Chinese Medical Journal, vol. 123, no. 10, pp. 1283–1288, 2010. View at Google Scholar
  27. S. Fenchel, D. Grab, K. Nuessle et al., “Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings,” Radiology, vol. 223, no. 3, pp. 780–788, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Koukouraki, L. G. Strauss, V. Georgoulias, M. Eisenhut, U. Haberkorn, and A. Dimitrakopoulou-Strauss, “Comparison of the pharmacokinetics of 68Ga-DOTATOC and 18FFDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 10, pp. 1115–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. W. Lee, B. S. Kim, D. S. Lee et al., “18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 11, pp. 1794–1802, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. S. Yap, C. Schiepers, M. C. Fishbein, M. E. Phelps, and J. Czernin, “FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 29, no. 9, pp. 1166–1173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Takamochi, J. Yoshida, K. Murakami et al., “Pitfalls in lymph node staging with positron emission tomography in non-small-cell lung cancer patients,” Lung Cancer, vol. 47, no. 2, pp. 235–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Koksal, F. Demirag, H. Bayiz et al., “The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients,” Journal of Cardiothoracic Surgery, vol. 8, no. 1, p. 63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Hellwig, T. P. Graeter, D. Ukena et al., “18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?” Journal of Nuclear Medicine, vol. 48, no. 11, pp. 1761–1766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. K. Kim, M. Allen-Auerbach, J. Goldin et al., “Accuracy of PET/CT in characterization of solitary pulmonary lesions,” Journal of Nuclear Medicine, vol. 48, no. 2, pp. 214–220, 2007. View at Google Scholar
  35. T. Berghmans, M. Dusart, M. Paesmans et al., “Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project,” Journal of Thoracic Oncology, vol. 3, no. 1, pp. 6–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Tsutani, Y. Miyata, H. Nakayama et al., “Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study,” Journal of Thoracic and Cardiovascular Surgery, vol. 143, no. 3, pp. 607–612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Yonetsu, M. Sumi, M. Izumi, M. Ohki, S. Eida, and T. Nakamura, “Contribution of Doppler sonography blood flow information to the diagnosis of metastatic cervical nodes in patients with head and neck cancer: assessment in relation to anatomic levels of the neck,” AJNR American Journal of Neuroradiology, vol. 22, no. 1, pp. 163–169, 2001. View at Google Scholar
  38. M. Sumi, M. Ohki, and T. Nakamura, “Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck,” American Journal of Roentgenology, vol. 176, no. 4, pp. 1019–1024, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Al-Ibraheem, A. Buck, B. J. Krause, K. Scheidhauer, and M. Schwaiger, “Clinical applications of FDG PET and PET/CT in head and neck cancer,” Journal of Oncology, vol. 2009, Article ID 208725, 13 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Scimeca, N. Urbano, R. Bonfiglio, O. Schillaci, and E. Bonanno, “Management of oncological patients in the digital era: anatomic pathology and nuclear medicine teamwork,” Future Oncology, vol. 14, no. 11, pp. 1013–1015, 2018. View at Publisher · View at Google Scholar · View at Scopus